Roberto Vendramin

8PUBLICATIONS
64CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Learning sciencesPredictive and prognostic markersHaematological tumoursCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 28, 2026
Immunotherapy drug target identification using machine learning and patient-derived tumour explant validation.

|Jan 12, 2026
Training Tomorrow's Leaders in Cancer Immunology.

Yuqi Tan, B J Kim, Adriana M Mujal

|Nov 07, 2025
The assembly of cancer-specific ribosomes by the lncRNA LISRR suppresses melanoma anti-tumor immunity.

Sonia Cinque, Yvessa Verheyden, Sara Adnane

|Sep 10, 2024
Genomic and immune heterogeneity of multiple synchronous lung adenocarcinoma at different developmental stages.

Yue Zhao, Jian Gao, Jun Wang

|Aug 30, 2021
Cancer evolution: Darwin and beyond.

Roberto Vendramin, Kevin Litchfield, Charles Swanton

|Jul 21, 2021
Activation of the integrated stress response confers vulnerability to mitoribosome-targeting antibiotics in melanoma.

Roberto Vendramin, Vicky Katopodi, Sonia Cinque

Pageof 2

Frequent Collaborators

3 joint publications

Eleonora Leucci

2 joint publications

Sonia Cinque

2 joint publications

Sara Adnane

2 joint publications

Yvessa Verheyden